Filana Therapeutics, Inc. (FLNA): Cash & Equivalents
$95.50M
As of 2025-12-31
$86.57M
As of 2026-03-31
-22.0%
3-year compound annual growth
+0.4%
5-year compound annual growth
+11.8%
10-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $95.50M | -25.7% | 2026-03-12, Balance as of period end |
| 2024-12-31 | $128.57M | +6.1% | 2026-03-12, Balance as of period end |
| 2023-12-31 | $121.14M | -39.7% | 2025-03-03, Balance as of period end |
| 2022-12-31 | $201.01M | -13.9% | 2024-02-28, Balance as of period end |
| 2021-12-31 | $233.44M | +149.6% | 2023-02-28, Balance as of period end |
| 2020-12-31 | $93.51M | +305.1% | 2022-03-01, Balance as of period end |
| 2019-12-31 | $23.08M | +16.5% | 2021-03-23, Balance as of period end |
| 2018-12-31 | $19.81M | +89.0% | 2020-03-26, Balance as of period end |
| 2017-12-31 | $10.48M | -36.9% | 2019-03-29, Balance as of period end |
| 2016-12-31 | $16.61M | -46.9% | 2018-02-06, Balance as of period end |
| 2015-12-31 | $31.30M | -22.9% | 2017-03-07, Balance as of period end |
| 2014-12-31 | $40.59M | -16.5% | 2017-03-07, Balance as of period end |
| 2013-12-31 | $48.59M | -1.6% | 2016-03-03, Balance as of period end |
| 2012-12-31 | $49.35M | -32.5% | 2015-02-18, Balance as of period end |
| 2011-12-31 | $73.14M | n/m | 2014-02-05, Balance as of period end |
| 2010-12-31 | $4.80M | -86.6% | 2013-02-08, Balance as of period end |
| 2009-12-31 | $35.79M | n/a | 2012-02-09, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| Filana Therapeutics, Inc. (FLNA) | 2025-12-31 | $95.50M | -25.7% |
| Camp4 Therapeutics Corp (CAMP) | 2025-12-31 | $109.52M | +71.0% |
| Aardvark Therapeutics, Inc. (AARD) | 2025-12-31 | $47.05M | -23.7% |
| Kyntra Bio, Inc. (KYNB) | 2025-12-31 | $47.87M | -5.2% |
| PMV Pharmaceuticals, Inc. (PMVP) | 2025-12-31 | $37.98M | -7.1% |
| Sagimet Biosciences Inc. (SGMT) | 2025-12-31 | $35.02M | -53.8% |
| Avalo Therapeutics, Inc. (AVTX) | 2025-12-31 | $15.86M | -88.2% |
| Rafael Holdings, Inc. (RFL) | 2025-07-31 | $52.77M | n/m |
| Milestone Pharmaceuticals Inc. (MIST) | 2025-12-31 | $73.05M | +188.6% |
Compare FLNA, CAMP, AARD, KYNB side by side · Screen every company in Pharmaceutical Preparations ↗